Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1958 1
1960 2
1961 2
1963 2
1965 1
1966 2
1967 2
1968 1
1969 3
1970 8
1971 2
1972 2
1973 5
1974 4
1975 3
1976 2
1978 1
1979 5
1980 2
1981 1
1982 4
1983 6
1985 1
1986 5
1987 6
1988 2
1989 8
1990 6
1991 3
1992 5
1993 2
1994 2
1995 14
1996 9
1997 6
1998 2
1999 5
2000 2
2001 5
2002 2
2003 1
2005 1
2006 1
2007 1
2008 1
2009 2
2010 1
2011 3
2012 6
2013 5
2014 4
2015 2
2016 4
2017 4
2018 4
2019 4
2020 4
2021 1
2022 3
2023 5
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

199 results

Results by year

Filters applied: . Clear all
Page 1
Noninvasive diagnosis by Doppler ultrasonography of fetal anemia due to maternal red-cell alloimmunization. Collaborative Group for Doppler Assessment of the Blood Velocity in Anemic Fetuses.
Mari G, Deter RL, Carpenter RL, Rahman F, Zimmerman R, Moise KJ Jr, Dorman KF, Ludomirsky A, Gonzalez R, Gomez R, Oz U, Detti L, Copel JA, Bahado-Singh R, Berry S, Martinez-Poyer J, Blackwell SC. Mari G, et al. Among authors: carpenter rl. N Engl J Med. 2000 Jan 6;342(1):9-14. doi: 10.1056/NEJM200001063420102. N Engl J Med. 2000. PMID: 10620643 Free article. Clinical Trial.
HSF1 as a Cancer Biomarker and Therapeutic Target.
Carpenter RL, Gökmen-Polar Y. Carpenter RL, et al. Curr Cancer Drug Targets. 2019;19(7):515-524. doi: 10.2174/1568009618666181018162117. Curr Cancer Drug Targets. 2019. PMID: 30338738 Free PMC article. Review.
NEDD4 degrades TUSC2 to promote glioblastoma progression.
Rimkus TK, Arrigo AB, Zhu D, Carpenter RL, Sirkisoon S, Doheny D, Regua AT, Wong GL, Manore S, Wagner C, Lin HK, Jin G, Ruiz J, Chan M, Debinski W, Lo HW. Rimkus TK, et al. Among authors: carpenter rl. Cancer Lett. 2022 Apr 10;531:124-135. doi: 10.1016/j.canlet.2022.01.029. Epub 2022 Feb 12. Cancer Lett. 2022. PMID: 35167936 Free PMC article.
Mechanism-based approaches to treating fragile X.
Dölen G, Carpenter RL, Ocain TD, Bear MF. Dölen G, et al. Among authors: carpenter rl. Pharmacol Ther. 2010 Jul;127(1):78-93. doi: 10.1016/j.pharmthera.2010.02.008. Epub 2010 Mar 18. Pharmacol Ther. 2010. PMID: 20303363 Review.
Drug development for neurodevelopmental disorders: lessons learned from fragile X syndrome.
Berry-Kravis EM, Lindemann L, Jønch AE, Apostol G, Bear MF, Carpenter RL, Crawley JN, Curie A, Des Portes V, Hossain F, Gasparini F, Gomez-Mancilla B, Hessl D, Loth E, Scharf SH, Wang PP, Von Raison F, Hagerman R, Spooren W, Jacquemont S. Berry-Kravis EM, et al. Among authors: carpenter rl. Nat Rev Drug Discov. 2018 Apr;17(4):280-299. doi: 10.1038/nrd.2017.221. Epub 2017 Dec 8. Nat Rev Drug Discov. 2018. PMID: 29217836 Free PMC article. Review.
Microwave injury.
Telles NC, Carpenter RL, Toker DL. Telles NC, et al. Among authors: carpenter rl. Arch Ophthalmol. 1970 Jul;84(1):127. doi: 10.1001/archopht.1970.00990040129028. Arch Ophthalmol. 1970. PMID: 5423598 No abstract available.
199 results